Antimicrobial

Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections

NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...

Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections

NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...

ARCHIMED Acquires a Majority Stake in Arkstone, Forging a Powerful Partnership to Accelerate Global Healthcare Innovation And Dominate the Emerging AI-Driven Clinical Decision Support Market

Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private...

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis

Premier research journal article provides validation for BiomX’s phage therapy platform, showcasing first-in-human Phase 1b/2a trial results for antibiotic-resistant P....

error: Content is protected !!